Table 2. Baseline demographics and... | American Society of Hematology

Table 2.

Baseline demographics and clinical characteristics of donors and patients with COVID-19 or ARDS-influenza who provided lung tissue specimens at autopsy

Patient	Age, y	Sex	Background	Ventilation, d	Anticoagulant
COVID-19
1	82	Male	Diffuse alveolar damage	0	Heparin
2	77	Male	Diffuse alveolar damage	2	Heparin
3	72	Male	Diffuse alveolar damage	6	Heparin
4	65	Male	Diffuse alveolar damage	33	Heparin
5	79	Female	Diffuse alveolar damage	2	Heparin
ARDS-influenza
1	67	Male	CAP	6	Heparin
2	72	Male	CAP	10	Heparin
3	77	Male	CAP	5	Heparin
4	81	Female	CAP	10	Heparin
5	80	Female	CAP	3	Heparin
Donor
1	82	Female	Recurrent myocardial infarction	0	No
2	75	Female	Heart and lung failure	0	Heparin
3	64	Male	Myocardial infarction	0	Heparin
4	77	Female	Dilated cardiomyopathy (right)	0	Heparin
5	75	Male	Dilated cardiomyopathy (right)	0	Heparin

Patient	Age, y	Sex	Background	Ventilation, d	Anticoagulant
COVID-19
1	82	Male	Diffuse alveolar damage	0	Heparin
2	77	Male	Diffuse alveolar damage	2	Heparin
3	72	Male	Diffuse alveolar damage	6	Heparin
4	65	Male	Diffuse alveolar damage	33	Heparin
5	79	Female	Diffuse alveolar damage	2	Heparin
ARDS-influenza
1	67	Male	CAP	6	Heparin
2	72	Male	CAP	10	Heparin
3	77	Male	CAP	5	Heparin
4	81	Female	CAP	10	Heparin
5	80	Female	CAP	3	Heparin
Donor
1	82	Female	Recurrent myocardial infarction	0	No
2	75	Female	Heart and lung failure	0	Heparin
3	64	Male	Myocardial infarction	0	Heparin
4	77	Female	Dilated cardiomyopathy (right)	0	Heparin
5	75	Male	Dilated cardiomyopathy (right)	0	Heparin

CAP, community-acquired pneumonia.